Atorvastatine, Supreme Court (Tribunal Supremo), 11 November 2011

search-result-placeholder.jpg

The Supreme Court dismissed an appeal , dismissing a revocation action against the patent in suit, which protected the calcium salt of atorvastatin. The Supreme court held that (i) the Bolar provision does not apply with retrospective effect, because its origin and rationale is different from the Experimental Use Exception; and (ii.) an invention that results from a selection between two lists of some length is new.

Click here for the full text of this case. A summary of this case will be posted on http://www.KluwerIPCases.com.

Comments (0)
Your email address will not be published.
Leave a Comment
Your email address will not be published.
Clear all
Become a contributor!
Interested in contributing? Submit your proposal for a blog post now and become a part of our legal community! Contact Editorial Guidelines
Image
AI Assistant on Kluwer IP Law's Manual IP
Image
Whitepaper

Book Ad List

Books
book1
Vissers Annotated European Patent Convention 2024 Edition
Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge
€105.00
AIPPI
Experimental Use and Bolar Exemptions
David Gilat, Charles A. Boulakia, Daphné Derouane & Ralph Nack
€190.00
book2
Annotated PCT
Malte Köllner
€160.00